Incidència: Per tasques de manteniment, el Dipòsit Digital només funciona per a la consulta.

 
Miniatura

Fitxers

657103.pdf (1.12 MB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2016-04

Llicència de publicació

cc-by-nc-nd (c) American Diabetes Association, 2016
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/135141

Dietary betaine supplementation increases Fgf21 levels to improve glucose homeostasis and reduce hepatic lipid accumulation in mice

Títol de la revista

Autors

ISSN de la revista

Títol del volum

Resum

Identifying markers of human insulin resistance may permit development of new approaches for treatment and prevention of type 2 diabetes. To this end, we analyzed the fasting plasma metabolome in metabolically characterized human volunteers across a spectrum of insulin resistance. We demonstrate that plasma betaine levels are reduced in insulin-resistant humans and correlate closely with insulin sensitivity. Moreover, betaine administration to mice with diet-induced obesity prevents the development of impaired glucose homeostasis, reduces hepatic lipid accumulation, increases white adipose oxidative capacity, and enhances whole-body energy expenditure. In parallel with these beneficial metabolic effects, betaine supplementation robustly increased hepatic and circulating fibroblast growth factor (Fgf)21 levels. Betaine administration failed to improve glucose homeostasis and liver fat content in Fgf21(-/-) mice, demonstrating that Fgf21 is necessary for betaine's beneficial effects. Together, these data indicate that dietary betaine increases Fgf21 levels to improve metabolic health in mice and suggest that betaine supplementation merits further investigation as a supplement for treatment or prevention of type 2 diabetes in humans.

Descripció

Matèries

Betaïna, Farmacologia, Fibroblasts, Factors de creixement, Sang, Glucosa, Metabolisme, Efectes secundaris dels medicaments, Fetge

Matèries (anglès)

Betaine, Pharmacology, Fibroblasts, Growth factors, Blood, Glucose, Metabolism, Drug side effects, Liver

Citació

Col·leccions

Articles publicats en revistes (Ciències Fisiològiques)
Articles publicats en revistes (Bioquímica i Biomedicina Molecular)

Citació

EJAZ, Asma, MARTINEZ-GUINO, Laura, GOLDFINE, Allison b., RIBAS AULINAS, Francesc, DE NIGRIS, Valeria, RIBÓ GENÉ, Sílvia, GONZÁLEZ FRANQUESA, Alba, GARCÍA-ROVES, Pablo m. (pablo miguel), LI, Elizabeth, DREYFUSS, Jonathan m., GALL, Walt, KIM, Jason k., BOTTIGLIERI, Teodoro, VILLARROYA I GOMBAU, Francesc, GERSZTEN, Robert e., PATTI, Mary-elizabeth, LERÍN MARTÍNEZ, Carlos. Dietary betaine supplementation increases Fgf21 levels to improve glucose homeostasis and reduce hepatic lipid accumulation in mice. _Diabetes_. 2016. Vol. 65, núm. 4, pàgs. 902-912. [consulta: 25 de novembre de 2025]. ISSN: 0012-1797. [Disponible a: https://hdl.handle.net/2445/135141]

Exportar metadades

JSON - METS

Compartir registre